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Abstract
AIM: To validate 4-sample lactose hydrogen breath 
testing (4SLHBT) compared to standard 13-sample 
LHBT in the clinical setting.
METHODS: Irritable bowel syndrome patients with 
diarrhea (IBS-D) and healthy volunteers (HVs) were 
enrolled and received a 10 g, 20 g, or 40 g dose 
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lactose hydrogen breath test (LHBT) in a randomized, 
double-blinded, controlled trial. The lactase gene 
promoter region was sequenced. Breath samples and 
symptoms were acquired at baseline and every 15 
min for 3 h (13 measurements). The detection rates 
of lactose malabsorption (LM) and lactose intolerance 
(LI) for a 4SLHBT that acquired four measurements at 
0, 90, 120, and 180 min from the same data set were 
compared with the results of standard LHBT.
RESULTS: Sixty IBS-D patients and 60 HVs were 
studied. The genotype in all participants was C/C-13910. 
LM and LI detection rates increased with lactose dose 
from 10 g, 20 g to 40 g in both groups (P  < 0.001). 
4SLHBT showed excellent diagnostic concordance with 
standard LHBT (97%-100%, Kappa 0.815-0.942) with 
high sensitivity (90%-100%) and specificity (100%) at 
all three lactose doses in both groups.
CONCLUSION: Reducing the number of measurements 
from 13 to 4 samples did not significantly impact on the 
accuracy of LHBT in health and IBS-D. 4SLHBT is a valid 
test for assessment of LM and LI in clinical practice.
Key words: Lactose hydrogen breath test; Diagnosis; 
Lactose malabsorption; Lactose intolerance; Irritable 
bowel syndrome
© The Author(s) 2015. Published by Baishideng Publishing 
Group Inc. All rights reserved.
Core tip: Lactose hydrogen breath test (LHBT) is the 
preferred method for clinical diagnosis of lactose 
malabsorption (LM) and lactose intolerance (LI); 
however, repeated measurements are time consuming 
and require dedicated personnel. In our study, we found 
4-sample LHBT has a high level of agreement with 
standard 13-breath sample for the clinical diagnosis 
of LM and LI. The 4SLHBT is a valid replacement for 
standard LHBT in clinical practice.
Yang JF, Fox M, Chu H, Zheng X, Long YQ, Pohl D, Fried M, 
Dai N. Four­sample lactose hydrogen breath test for diagnosis 
of lactose malabsorption in irritable bowel syndrome patients 
with diarrhea. World J Gastroenterol 2015; 21(24): 7563­7570 
Available from: URL: http://www.wjgnet.com/1007­9327/full/
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INTRODUCTION
Lactose malabsorption (LM) and lactose intolerance 
(LI) are common conditions affecting many of the 
world’s adult population[1]. The prevalence of these 
condition ranges from below 10% in Northern Europe 
to over 90% in China and Southeast Asia[2-4]. Lactose 
hydrogen breath test (LHBT) remains the preferred 
method for the clinical diagnosis of LM and LI[5,6]. 
In the presence of intestinal brush-border enzyme 
lactase, lactose is cleaved into the readily absorbable 
monosaccharides glucose and galactose. If lactase 
expression has reduced after weaning or if lactase 
activity is suppressed [i.e., primary or secondary 
lactase deficiency (LD)], unabsorbed lactose reaches 
the colon. Here it is fermented by the commensal flora 
to produce small chain fatty acids and, as a byproduct, 
hydrogen (H2). Hydrogen quickly diffuses through 
the intestinal mucosa into the venous bloodstream 
and is then exhaled through the lungs. Quantification 
of hydrogen in exhaled breath, as acquired in the 
hydrogen breath test, provides objective information 
regarding digestion and absorption of lactose.
Performing a LHBT is a time-consuming process 
that requires dedicated personnel. After baseline 
measurements and ingestion of lactose, breath 
hydrogen concentration and abdominal symptoms 
are measured every 15 min for 3-6 h. If the breath 
hydrogen concentration exceeds a given threshold 
(e.g., 20 ppm) from the baseline for two consecutive 
measurements, LM is diagnosed; in addition, if clinically 
relevant abdominal symptoms develop with or soon 
after an increase in breath hydrogen, then LI is 
diagnosed[1,7].
In 2002, Enattah et al[8] reported the single-
nucleotide polymorphism C/T-13 910 above the 
structural gene coding for the enzyme lactose on the 
short arm of chromosome 2q.21-22. Many recent 
studies have shown that CC-13910 is a good predictor 
of LM and LI; there was an excellent agreement 
between genetic testing of lactose C/T-13 910 and 
LHBT[9,10]. With LHBT as the gold standard, the 
CC-13 910 genotype had a high sensitivity (97%) 
and specificity (95%) with high kα value (0.9) in 
diagnosing LM[11]. For the diagnosis of LM, compared 
to genetic testing, LHBT has been shown to range 
in sensitivity between 76%-94% and specificity of 
77%-96%[12]. Additionally, LHBT could identify patients 
with LI who experience symptoms associated with 
LM. Disadvantages that impact the clinical application 
of LHBT are long testing time (typically 3-6 h), and 
tedious process (breath hydrogen concentration is 
measured every 15 min), which not only affect the 
patient’s compliance but also demand considerable 
medical resources. It has been reported that a 
simplified test procedure with hydrogen measurements 
at three time points (between 0 and 180 min) after a 
high dose (40-50 g) oral lactose challenge maintained 
high sensitivity and specificity for the diagnosis of LM 
and LI[13-15]. These high doses of lactose are appropriate 
for epidemiological studies; however, lower doses 
may be more relevant in clinical studies since 10-20 g 
lactose is more typical of the normal diet[16,17]. Further 
intolerance to these low- and intermediate-doses of 
lactose is characteristic in irritable bowel syndrome 
patients with diarrhea (IBS-D), a chronic functional 
bowel disorder that is characterized by visceral 
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hypersensitivity to physiological stimuli[18,19]. These 
findings may help to identify patients with unexplained 
abdominal symptoms[20] and IBS-D patients[21,22] who 
could benefit from dietary managements.
In recent studies, we found that hydrogen breath 
concentration at all three doses (10 g, 20 g, 40 g) of 
lactose most often increased after 90 min of lactose 
intake and peaked between 150-180 min. Based on 
a sensitivity analysis of a large dataset and practical 
considerations, we hypothesized that reducing the 
number of LHBT within those time points, specifically 0, 
90, 120, and 180 min (Four-Sample Lactose Hydrogen 
Breath Test, 4SLHBT), would not significantly impact 
the performance of LHBT at a low-dose (10 g, 
“control”), intermediate-dose (20 g, reflecting typical 
intake at a single meal) and high-dose (40 g, “reference 
standard”) lactose. The objective of this study was to 
test this hypothesis and validate the performance and 
clinical utility of 4SLHBT by comparing it with standard 
LHBT in the diagnosis of LM and LI among healthy 
volunteers (HVs) and IBS-D patients who received 
various doses of lactose.
MATERIALS AND METHODS
Study population
IBS-D group: Consecutive IBS-D patients seen at 
the Gastroenterology Clinic of Sir Run Run Shaw 
Hospital, Zhejiang University School of Medicine from 
September 2009 to August 2010 were enrolled into 
this trial. IBS-D was diagnosed with Rome Ⅲ criteria 
after screening for alarm criteria[23] and excluding 
structural gastrointestinal pathology where clinically 
indicated. The control group consisted of HVs with no 
history of gastrointestinal disorders recruited at the 
same time from the urban community in Hangzhou.
Study design
Eligible participants completed genetic sequencing of 
the lactase gene regulatory sequence and a question-
naire about food containing lactose. A randomized, 
double-blinded, three-way cross-over trial was performed. 
All IBS-D patients and HVs underwent LHBT after 
an oral load of lactose at doses of 10 g, 20 g, and 
40 g. The interval between each test was 7-14 d in 
randomized order using a random number table. 
The lactose meal was prepared by a researcher not 
involved in the examination. This researcher randomly 
assigned lactose dose and marked the order on 
disposable cups. Both the subjects and examiner were 
blinded from the lactose dose information.
Genetic sequencing of lactase gene regulatory 
sequence (genotype)
White cells were isolated from a whole blood sample 
using a modified salting-out procedure, and DNA 
was extracted (Axygen, Union City, CA, United 
States). A 446-bp region within intron 13 of MCM6 
(13807bp to 14253bp upstream of the lactase gene) 
was amplified by 35 PCR cycles [forward primer 
(5’-CGGATGCACTGCTGTGATGA-3’), reverse primer 
(5’-ACTGACCTATCCTCGTGGAATG-3’)]. Single 
Nucleotide Polymorphisms (SNPs) associated with 
lactase persistence in European (C/T-13910), African 
and Arabian (C/G-13907, T/G-13915, G/C-14010) 
populations were identified by bi-directional sequencing 
using Sequencher software (vs 4.0.5, GeneCodes)[8,24].
Lactose hydrogen breath test
Laboratory equipment: Handheld hydrogen bre-
ath tester (Micro H2 Meter, Micro Medical Limited, 
England), reset before the test and calibrated with 
standard 100 ppm hydrogen (Micro Medical Limited, 
England).
Preparation before the test: Subjects were restricted 
from taking antibiotics and probiotics for one month and 
prokinetics at least 1 week before the test. Subjects 
refrained from eating dairy products, soy products, and 
other foods rich in fiber one day before the test.
Test procedure: Breath hydrogen concentration 
was measured twice for each subject in the fasted 
state before the test. The average value was taken 
as baseline. Then subjects drank lactose solution (10 
g, 20 g, or 40 g lactose dissolved in 250 mL warm 
water), followed by breath hydrogen testing every 
15 min for 3 h. Gastrointestinal symptoms, including 
nausea, bloating, borborygmi, abdominal pain and 
diarrhea, were also recorded during the trial. Subjects 
refrained from food/drink, smoking and strenuous 
activity during the trial.
Symptom score: The severity of gastrointestinal 
symptoms: nausea, bloating, borborygmus, abdominal 
pain, diarrhea, was self-assessed by the subjects 
using a 5-level visual rating scale: none, mild, 
moderate, severe, and very severe, scored from 0 to 
4 points respectively. The highest rating score from 
each symptom was then added to calculate the total 
symptom score. Subjects were also interviewed for 
above gastrointestinal symptoms within 24 h after trial 
completion by telephone, and rated their maximum 
symptoms as per the visual scale.
Diagnostic criteria: LM was diagnosed if patients’ 
hydrogen breath concentration elevated more than 20 
ppm from baseline twice consecutively within three 
hours of the testing period. LI was diagnosed if patients 
met LM diagnostic criteria, and had a one-point or 
more increase in the severity of above-mentioned 
gastrointestinal symptoms above baseline occurring 
more than twice during the 24 h follow-up period.
Statistical analysis
4SLHBT analysis values were derived from the same 
data set of hydrogen breath samples of standard LHBT 
at 0, 90, 120, and 180 min. Outcomes of interest 
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Table 1  Lactose malabsorption and lactose intolerance 
detection rates in three-dose lactose hydrogen breath test  n  (%)
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included: (1) incidence of LM, LI with various lactose 
doses using LHBT; (2) H2 peak (P): the maximum 
hydrogen breath values  (ppm), time to H2 peak (Tp): 
the time (min) taken from baseline to maximum 
hydrogen value; and (3) sensitivity of LM and LI 
diagnosis with the 4SLHBT method, using standard 
LHBT as reference (measuring every 15 min within 
3 h of lactose intake). The primary analysis was the 
concordance rate between the two methods.
The Kolmogorov-Smirnov test was used for normal 
distribution test of continuous variables. Normally 
distributed data were summarized using mean ± SD, 
and the rates between two groups were compared 
using a χ 2 test. All analyses were performed with SPSS 
16.0 statistical software (SPSS, Chicago, IL, United 
States). P ≤ 0.05 was regarded as significant.
RESULTS
Characteristics of IBS-D and HV subjects
The study enrolled 63 IBS-D patients and 64 healthy 
volunteers, who completed LHBT at all 3 lactose dose 
levels (10 g, 20 g, 40 g). Of them, 3 IBS-D patients 
and 4 HVs were excluded from the final analysis due 
to hydrogen breath value > 20 ppm at baseline. Thus, 
the final study population included 60 IBS-D patients 
and 60 HVs.
Genotype
The genotype in all participants was C/C-13910 and 
no other SNP was identified on gene sequencing of 
the putative lactase gene regulatory sequence in any 
participant irrespective of group or phenotype defined 
by LHBT.
Detection rate of LM and LI
In IBS-D patients, with increasing dose of lactose 
intake (10 g, 20 g, 40 g), LM detection rates increased 
gradually from 41.6%, 86.6%, to 93.3%, respectively; 
LI detection rates increased from 18.3%, 46.7%, to 
85%, respectively.
In the control group, with increasing dose of lactose 
intake (10 g, 20 g, 40 g), LM detection rates increased 
gradually from 35%, 80%, to 91.6%, respectively; 
and LI detection rates increased from 3.3% to 21.7% 
and 68.3%, respectively (Table 1).
Hydrogen peak and time to the peak
With increasing dose of lactose, H2 peaks  were 
significantly higher (P < 0.01) in both the IBS-D and 
HV groups. Mean time to H2 peak in IBS-D group by 
lactose dose was: 153.5 ± 32.9 min (10 g), 151.5 
± 35.9 min (20 g), and 151.3 ± 29.6 min (40 g), 
respectively (P = 0.875). In the HV group the time to 
H2 peak by lactose dose was measured as 152.1 ± 
25.2 min (10 g), 148.1 ± 30.7 min (20 g) and 139.3 ± 
30.0 min (40 g) P = 0.357) (Table 2). In 96.1% (49/51) 
IBS-D patients and 92.7% (38/41) HVs, LI symptoms 
occurred between 90-180 min after lactose intake.
Comparison between standard LHBT and 4SLHBT for 
diagnosis of LM and LI
In both the IBS-D and HV groups, the diagnostic yield 
of LHBT increased over time for all lactose doses (10 
g, 20 g, 40 g), reaching a peak at 150-180 min after 
lactose consumption (Figure 1A and B).
In the IBS-D group, 4SLHBT and standard LHBT 
showed high agreement for LM [Kappa = 0.93 (10 
g), 0.87 (20 g), 0.88 (40 g)] and LI diagnosis (Kappa 
= 0.94 (10 g), 0.93 (20 g), 0.84 (40 g); compared 
to standard LHBT, 4SLHBT had high sensitivity 
(91%-98%) and specificity (100%) in detecting LM 
and LI in three-dose LHBT.
In the HV group, 4SLHBT and standard LHBT also 
showed high agreement for LM [Kappa = 0.93 (10 g), 
0.90 (20 g), 0.82 (40 g)] and LI diagnosis (Kappa = 1.0 
(10 g), 0.95 (20 g), 0.89 (40 g); compared to standard 
LHBT, 4SLHBT had high sensitivity (90%-100%) and 
specificity (100%) in detecting LM and LI in three-dose 
LHBT.
Agreement, sensitivity, specificity, positive predictive 
value, and negative predictive value of 4SLHBT are 
summarized in Tables 3 and 4.
DISCUSSION
This study determined the performance of a simplified 
four-sample LHBT (4SLHBT) method in a population 
with high prevalence of LD. LHBT is the “standard” test 
for the clinical diagnosis of LM and LI[16]. At high doses 
this test has a high sensitivity for the diagnosis of LM 
and can detect elevated breath hydrogen levels from 
bacterial degradation of as little as 2-6 g lactose in the 
colon[25]. In this study, the genotype in all participants 
was C/C-13910 and no other SNP associated with 
lactase persistence was present in the lactase gene 
regulatory sequence, which confirmed 100% of 
participants had LD. Compared to the genetic test, 20 
g and 40 g LHBT provided an accurate diagnosis of 
LM with 87% and 93% sensitivity, respectively. Even 
this may be an underestimate because 4 patients 
(6.7%) reported typical LI symptoms without an 
Lactose dose
10 g 20 g 40 g
IBS-D LM    25 (41.6)    52 (86.6)    56 (93.3)
LI    11 (18.3)    28 (46.7) 51 (85)
HVs LM 21 (35) 48 (80)    55 (91.6)
LI    2 (3.3)    13 (21.7)    41 (68.3)
LM: Lactose malabsorption; LI: Lactose intolerance; IBS-D: Irritable bowel 
syndrome patients with diarrhea; HVs: Healthy volunteers.
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Table 2  H2 peak and time to H2 peak in three-dose lactose hydrogen breath test
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increase in breath hydrogen, likely to be false negative 
findings because colonic fermentation did not produce 
hydrogen in these individuals[1,26]. This finding confirms 
that LHBT provides an accurate assessment of LM. 
The results of this study also showed that the H2 
peak increased with the dose in a dose-dependent 
manner from 10 g to 20 g and 40 g. High H2 peak 
values above 100 ppm may be of clinical interest 
because these are associated with increased bloating 
and, especially, borborygmi, as found in recent clinical 
studies performed in the same population[18,19].
Conventional LHBT is time-consuming (usually takes 
3-6 h) and requires multiple hydrogen breath tests 
(once every 15 min). This tedious process may have a 
Lactose dose P  value
10 g 20 g 40 g 10 g vs  20 g 20 g vs  40 g
IBS-D H2 peak 38.5 57 92 0.010 0.000
(ppm) (27.3-47.3) (32.0-85.0) (58.0-127.0)
Tp 153.5 ± 32.9 151.5 ± 35.9 151.3 ± 29.6 0.702 0.613
(min)
HVs H2 peak 38 66 99 0.004 0.001
(ppm) (29.5-46) (36.5-90.5) (56.5-135.5)
Tp 152.1 ± 25.2 148.1 ± 30.7 139.3 ± 30.0 0.602 0.127
(min)
IBS-D: Irritable bowel syndrome patients with diarrhea; HVs: Healthy volunteers; Tp: Time to H2 peak.
Figure 1  Lactose malabsorption and lactose intolerance detection rates over time in irritable bowel syndrome patients with diarrhea group (A) and healthy 
volunteer group (B). The detection rates of LM and LI increased over time and reached a peak at 150-180 min interval. LM: Lactose malabsorption; LI: Lactose 
intolerance; IBS-D: Irritable bowel syndrome patients with diarrhea.
LM 10 g
LM 20 g
LM 40 g
LI 10 g
LI 20 g
LI 40 g
LM 10 g
LM 20 g
LM 40 g
LI 10 g
LI 20 g
LI 40 g
HVs
100
90
80
70
60
50
40
30
20
10
0
Th
e 
pr
ec
en
ta
ge
 o
f 
LM
 a
nd
 L
I 
(%
)
0        15        30       45        60       75       90       105     120      135      150     165      180
t /min
Patients with IBS-D
100
90
80
70
60
50
40
30
20
10
0
Th
e 
pr
ec
en
ta
ge
 o
f 
LM
 a
nd
 L
I 
(%
)
0        15        30       45        60       75       90       105     120      135      150     165      180
t /min
A
B
Yang JF et al . Four-sample lactose hydrogen breath test
Table 4  Sensitivity, specificity, positive predictive value, negative predictive value of 4-sample lactose hydrogen breath testing 
method using standard lactose hydrogen breath test method as the reference
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negative impact on its clinical application and patient’s 
compliance. Several studies have investigated whether 
reducing the number of hydrogen breath samples in 
LHBT impacts on the sensitivity of LM diagnosis[13-15]. 
Compared to standard LHBT with samples taken 
every 15 min over 3 h, our Swiss study showed that 
three-sample tests had sensitivity and specificity of 
83.4 and 99.7% (0-60-90 min), 95.0 and 99.2% 
(0-60-120 min), and 95.0 and 98.9% (0-90-120 min), 
respectively[15]. Similar results were reported by Di 
Camillo et al[14]; measurements at baseline, 120 min 
and 180 min had low false-negative results for LM 
(5.9%) compared to measurements taken every 30 min 
for 4 h. However, both these studies used high-dose 
lactose (50 g, equivalent of 1 liter of milk) and were 
conducted primarily to establish the presence of LM in 
a population with low prevalence of LD. In China, LD is 
universal and, therefore, the focus of study is to identify 
patients who experience abdominal symptoms at low 
doses of lactose found in the normal diet. The results 
of this study showed that with 3 lactose loading doses, 
10g, 20 g, and 40 g, 4SLHBT achieved high sensitivity 
(LM > 92%, LI > 91%) and specificity (100%) for both 
LM and LI diagnosis compared to the standard method 
at all three doses. The primary analysis showed a high 
level of concordance between standard and 4SLHBT 
methods (97%-100%) with excellent agreement 
confirmed by the Kappa statistic (0.815-0.942).
As previous studies have shown[13-15], three samples 
(0, 120, 180) were also almost as equally helpful in 
diagnosing LM compared with 4 samples (0, 90, 120, 
180) for LHBT in our study. Considering small intestinal 
bacterial overgrowths (SIBO) could bring about false 
positive results on LHBT, the H2 value of 90 min 
could help us estimate whether the participant had 
SIBO. When this point value is very high, even higher 
than that of 120 min or 180 min, SIBO should be 
considered since oro-caecal transit time in this study 
population is 60-90 min[27,28]. However, in a population 
with high prevalence of LD, SIBO would not alter the 
Table 3  Agreement of lactose malabsorption and lactose intolerance diagnosis between 4-sample lactose hydrogen breath testing 
and standard lactose hydrogen breath testing methods
Standard LHBT
4SLHBT LM LI
IBS-D (+) (-) Kappa P value (+) (-) Kappa P value
10 g (+) 23   0 0.931 < 0.001 10   0 0.942 < 0.001
(-)   2 35   1 49
20 g (+) 50   0 0.870 < 0.001 26   0 0.933 < 0.001
(-)   2   8   2 32
40 g (+) 55   0 0.880 < 0.001 47   0 0.839 < 0.001
(-)   1   4   3 10
HVs
10 g (+) 19   0 0.925 < 0.001   2   0 1.000 < 0.001
(-)   2 39   0 58
20 g (+) 46   0 0.902 < 0.001 12   0 0.949 < 0.001
(-)   2 12   1 47
40 g (+) 53   0 0.815 < 0.001 38   0 0.889 < 0.001
(-)   2   5   3 19
LHBT: Lactose hydrogen breath test; LM: Lactose malabsorption; LI: Lactose intolerance; 4SLHBT: 4-Sample Lactose Hydrogen Breath Testing; IBS-D: 
Irritable bowel syndrome patients with diarrhea; HVs: Healthy volunteers.
LHBT Sensitivity Specificity PPV NPV
IBS-D 10 g LM   92% 100% 100% 94.6%
LI   91% 100% 100%    98%
20 g LM   96% 100% 100%    80%
LI   93% 100% 100% 94.1%
40 g LM   98% 100% 100%    80%
LI   94% 100% 100% 76.9%
HVs 10 g LM   90% 100% 100% 95.1%
LI 100% 100% 100%  100%
20 g LM   96% 100% 100% 85.7%
LI   92% 100% 100% 97.9%
40 g LM   96% 100% 100% 71.4%
LI   93% 100% 100% 86.4%
LHBT: Lactose hydrogen breath test; LM: Lactose malabsorption; LI: Lactose intolerance; 4SLHBT: 4-Sample Lactose Hydrogen Breath Testing; IBS-D: 
Irritable bowel syndrome patients with diarrhea; HVs: Healthy volunteers; PPV: Positive predictive value; NPV: Negative predictive value.
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number of patients diagnosed with LM.
This study has some important strengths: (1) A 
total of 120 subjects was recruited, a large number 
compared to most other validation studies; (2) not 
only healthy subjects, but also IBS-D patients were 
recruited, a group that often present with self-reported 
food intolerance and are often referred for LHBT; (3) 
genetic testing was used as a gold-standard to confirm 
the presence of LD; and (4) diagnostic agreement was 
checked at multiple lactose doses confirming that the 
4SLHBT can be applied at high doses for diagnosis 
of LM and also at low doses for diagnosis of LI at the 
levels found in the normal diet.
Limitations of the study include: (1) performance 
of studies in a Chinese population with primary LD 
could limit generalizability; however, previous studies 
have shown that a similar proportion of patients with 
LD in Western populations have lactose malabsorption 
and intolerance. Further, in the same cohort, reduced 
breath test sampling is adequate at high doses[14,15]; 
and (2) the duration of the standard LHBT was 
limited to 3 h which is shorter than that used by 
some other authors (up to 6 h). This decision was 
based on published experience with a combined LHBT 
scintigraphy test that showed oro-caecal transit time 
in the study population of 60-90 min[27,28]. Moreover, 
in the present study, breath hydrogen increased after 
a median 90 min and peaked at a median 150 min 
with the vast majority (93%) of participants reporting 
symptoms 90-180 min after the ingestion of lactose; 
only five individuals reported symptoms after the 
study at 24 h follow-up. Two IBS-D patients developed 
moderate diarrhea at 215 min, 245 min after lactose 
intake. One HV developed severe diarrhea at 230 min, 
two HVs developed severe bloating and borborygmi in 
255, 300 min after lactose intake. The primary aim of 
this study was to validate 4SLHBT and not to improve 
the specificity of LM and LI diagnosis by LHBT.
In conclusion, these findings demonstrate a high 
level of agreement between standard 13-breath-
sample and 4-sample LHBT for the clinical diagnosis 
of LM and LI. The 4SLHBT provided accurate results at 
high doses for formal diagnosis of LM and also at low 
doses for diagnosis of clinically relevant LI. Reducing 
the number of breath samples will free up personnel 
and allow more patients to take LHBT simultaneously, 
thus making best use of limited medical resources. 
The 4SLHBT is a valid replacement for standard LHBT 
in clinical practice.
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COMMENTS
Background
Lactose hydrogen breath tests (LHBT) are widely used to diagnose lactose 
malabsorption (LM) and lactose intolerance (LI). The main time-consuming part 
of the test relates to the sampling frequency and number of breath samples.
Research frontiers
There are many different protocols to simplify LHBT; however, most of these 
studies used high-dose lactose (50 g) and were conducted in a population with 
low prevalence of lactase deficiency.
Innovations and breakthroughs
Four-sample lactose hydrogen breath test (4SLHBT) showed high diagnostic 
agreement with standard LHBT (97%-100%, Kappa 0.815-0.942) with high 
sensitivity (90%-100%) and specificity (100%) at all three lactose doses in both 
study groups.
Applications
Reducing the number of measurements of breath hydrogen and symptoms 
from 13 to 4 samples did not impact on the LHBT results in health and IBS-D. 
4SLHBT is a valid test for assessment of LM and LI in clinical practice.
Peer-review
This is a very interesting study. The authors assessed diagnostic accuracy of 
4-sample LHBT compared to standard 13-sample LHBT and genetic tests of 
primary lactase deficiency in 60 irritable bowel syndrome patients with diarrhea 
and 60 healthy volunteers with a 10 g, 20 g, or 40 g lactose dose. The authors 
found 4-sample LHBT has excellent sensitivity and specificity for LM and LI. 
LHBT can be simplified to 4 samples (0, 90, 120, 180).
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